Literature DB >> 15774952

Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness.

Christian R Dolder1, Kari Furtek, Jonathan P Lacro, Dilip V Jeste.   

Abstract

The authors compared antihypertensive medication adherence and blood pressure control among middle-aged and older outpatients with schizophrenia and related those with psychotic disorders versus persons without any psychiatric illness. A total of 178 subjects were included in the investigation (89 patients with a psychotic disorder and 89 randomly selected, age-matched comparison subjects). Although the two groups had similar antihypertensive medication adherence, the patients with a psychotic disorder were significantly less likely to have had controlled blood pressure during the 1-year study period. The results highlight the need for clinicians to monitor closely the management of medical comorbidity in patients with schizophrenia and related disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774952     DOI: 10.1176/appi.psy.46.2.135

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  13 in total

1.  Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans.

Authors:  Lydia A Chwastiak; Robert A Rosenheck; Lewis E Kazis
Journal:  Psychosomatics       Date:  2011 May-Jun       Impact factor: 2.386

2.  Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness.

Authors:  Ashli Owen-Smith; Christine Stewart; Carla Green; Brian K Ahmedani; Beth E Waitzfelder; Rebecca Rossom; Laurel A Copeland; Gregory E Simon
Journal:  Gen Hosp Psychiatry       Date:  2015-07-30       Impact factor: 3.238

3.  A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness.

Authors:  Julie Kreyenbuhl; Jaclyn Leith; Deborah R Medoff; Lijuan Fang; Faith B Dickerson; Clayton H Brown; Richard W Goldberg; Wendy Potts; Lisa B Dixon
Journal:  Psychiatry Res       Date:  2011-04-02       Impact factor: 3.222

4.  Extended release drug delivery strategies in psychiatry: theory to practice.

Authors:  Steven J Siegel
Journal:  Psychiatry (Edgmont)       Date:  2005-06

5.  Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease.

Authors:  E Stuebner; E Vichayanrat; D A Low; C J Mathias; S Isenmann; C A Haensch
Journal:  Clin Auton Res       Date:  2015-02-18       Impact factor: 4.435

6.  Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial.

Authors:  Masumeh Hosseininasab; Zahra Jahangard-Rafsanjani; Abbas Mohagheghi; Amir Sarayani; Arash Rashidian; Mohammadreza Javadi; Alireza Ahmadvand; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  Am J Hypertens       Date:  2014-04-26       Impact factor: 2.689

7.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

8.  Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?

Authors:  Julie Kreyenbuhl; Lisa B Dixon; John F McCarthy; Soheil Soliman; Rosalinda V Ignacio; Marcia Valenstein
Journal:  Schizophr Bull       Date:  2008-08-20       Impact factor: 9.306

9.  The role of comorbidities in patients' hypertension self-management.

Authors:  Gemmae M Fix; Ellen S Cohn; Jeffrey L Solomon; Dharma E Cortés; Nora Mueller; Nancy R Kressin; Ann Borzecki; Lois A Katz; Barbara G Bokhour
Journal:  Chronic Illn       Date:  2013-07-26

Review 10.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.